2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$3.88+$0.02 (+0.65%)
Price as of Aug 21, 2026 7:59 PM EDT- $227.5MMarket Cap
- 23.79%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$3.88+$0.02 (+0.65%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.85 | ||
Change | -$0.05 (-1.28%) | ||
Open | $3.91 | ||
High | $3.95 | ||
Low | $3.81 | ||
Previous Close | $3.90 | ||
Volume | 238,444 | ||
30-Day Average Volume | 381,990 | ||
1-Week Change | -3.02% | ||
1-Month Change | -5.87% | ||
1-Year Change | 23.79% | ||
3-Year Change | 65.24% | ||
5-Year Change | -43.55% | ||
Fundamentals | |||
Shares Outstanding | 59.1M | ||
Total Assets | $176.1M | ||
Market Cap | $227.5M | ||
Enterprise Value | $210.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$21.7M | ||
Free Cash Flow | -$15.4M | ||
EBIT | -$21.7M | ||
EBITDA | -$21.6M | ||
Net Working Capital | $132.8M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 142 | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | 1 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue